Healthtech can be said to have a mixed 2022 but Glamyo Health was able to register growth. Please take us through some of the high points and where this places you now in the marketplace.
Last year, Glamyo Health witnessed significant growth in both the number of patients counselled on the platform as well as the number of doctors we have on our platform. The number of patients who received free medical counselling increased to 600K and our website witnessed over 10 lakh visits.
Despite three Covid-related disruptions, we focused on the elective surgeries market and were able to scale to nearly six crore medical counselling sessions for patients in need. We have over 350 hospitals in the network now and we also raised $7 million so far. We are currently in Series B discussions.
I recall when we had begun, even attracting good-quality talent to join us and then retaining them was a big challenge but now we have been able to do so with good management strategies.
What were some of the specific steps you undertook last year, especially given the uncertainty in the startup ecosystem?
Over the last 12 months, easy access to capital has considerably waned. This has required a fair bit of change in the strategy, and the age-old adage of profitable growth has come to the forefront again. We continued to focus on the basics and tweaked our offerings with that in mind.
Glamyo Health has renewed its focus on solving the real pain points for the patients, added newer verticals like dental, which is a blue ocean market, and tightened its grip on costs with a focus on profitable growth. We have also been looking at alternate channels of demand generation to replace the digital-first channels of demand.
Is there a mantra or a principle that you follow as you lead your teams or plan your next steps?
Glamyo Health’s success mantra has been its razor-sharp focus on execution, with the patient at the centre of all the offerings. Moreover, we have been broad-basing the demand generation from only online to a mix of online and offline, which has proved to be quite useful.